ICCM
Price
$1.00
Change
-$0.08 (-7.41%)
Updated
Oct 22 closing price
Capitalization
4.64M
27 days until earnings call
Intraday BUY SELL Signals
SINT
Price
$1.65
Change
-$0.07 (-4.07%)
Updated
Oct 22 closing price
Capitalization
11M
20 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ICCM vs SINT

ICCM vs SINT Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ICCM vs. SINT commentary
Oct 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ICCM is a Hold and SINT is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ICCM with price predictions
Oct 22, 2026

ICCM's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for ICCM turned positive on October 19, 2026. Looking at past instances where ICCM's MACD turned positive, the stock continued to rise in 40 of 49 cases over the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 49 of 66 cases where ICCM's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 74%.

Following a +3.85% 3-day Advance, the price is estimated to grow further. Considering data from situations where ICCM advanced for three days, in 161 of 208 cases, the price rose further within the following month. The odds of a continued upward trend are 77%.

ICCM may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ICCM declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 88%.

The Aroon Indicator for ICCM entered a downward trend on October 22, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 7 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 47 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.390) is normal, around the industry mean (2.874). P/E Ratio (-0.147) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (1.297) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 96 (best 1 - 100 worst), indicating slightly worse than average price growth. ICCM’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. ICCM’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

A.I.Advisor
a Summary for SINT with price predictions
Oct 22, 2026

Momentum Indicator for SINT turns negative, indicating new downward trend

SINT saw its Momentum Indicator move below the 0 level on October 14, 2026. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 89 similar instances where the indicator turned negative. In 82 of the 89 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for SINT turned negative on October 13, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 46 similar instances when the indicator turned negative. In 43 of the 46 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.

SINT moved below its 50-day moving average on October 15, 2026 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SINT declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for SINT's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 6 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +12.06% 3-day Advance, the price is estimated to grow further. Considering data from situations where SINT advanced for three days, in 164 of 203 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

SINT may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 54 of 66 cases where SINT Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 82%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 47 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 53 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.277) is normal, around the industry mean (2.874). P/E Ratio (-0.301) is within average values for comparable stocks, (2.324). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (6.057) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 62 (best 1 - 100 worst), indicating steady price growth. SINT’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SINT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
ICCM vs SINT: Fundamental Ratings
ICCM
SINT
OUTLOOK RATING
1..100
367
VALUATION
overvalued / fair valued / undervalued
1..100
47
Fair valued
53
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
9662
P/E GROWTH RATING
1..100
747
SEASONALITY SCORE
1..100
17n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ICCM's Valuation (47) in the null industry is in the same range as SINT (53) in the Medical Specialties industry. This means that ICCM’s stock grew similarly to SINT’s over the last 12 months.

ICCM's Profit vs Risk Rating (100) in the null industry is in the same range as SINT (100) in the Medical Specialties industry. This means that ICCM’s stock grew similarly to SINT’s over the last 12 months.

ICCM's SMR Rating (100) in the null industry is in the same range as SINT (100) in the Medical Specialties industry. This means that ICCM’s stock grew similarly to SINT’s over the last 12 months.

SINT's Price Growth Rating (62) in the Medical Specialties industry is somewhat better than the same rating for ICCM (96) in the null industry. This means that SINT’s stock grew somewhat faster than ICCM’s over the last 12 months.

ICCM's P/E Growth Rating (7) in the null industry is somewhat better than the same rating for SINT (47) in the Medical Specialties industry. This means that ICCM’s stock grew somewhat faster than SINT’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ICCMSINT
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
88%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
74%
Bullish Trend 1 day ago
90%
Momentum
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 4 days ago
77%
Bullish Trend 23 days ago
81%
Declines
ODDS (%)
Bearish Trend 11 days ago
88%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
76%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
82%
COMPARISON
Comparison
Oct 23, 2026
Stock price -- (ICCM: $1.08 vs. SINT: $1.72)
Brand notoriety: ICCM and SINT are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ICCM: 87% vs. SINT: 36%
Market capitalization -- ICCM: $4.64M vs. SINT: $11M
ICCM [@Medical/Nursing Services] is valued at $4.64M. SINT’s [@Medical/Nursing Services] market capitalization is $11M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $173.92B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.76B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ICCM’s FA Score shows that 1 FA rating(s) are green while SINT’s FA Score has 0 green FA rating(s).

  • ICCM’s FA Score: 1 green, 4 red.
  • SINT’s FA Score: 0 green, 5 red.
According to our system of comparison, ICCM is a better buy in the long-term than SINT.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ICCM’s TA Score shows that 4 TA indicator(s) are bullish while SINT’s TA Score has 5 bullish TA indicator(s).

  • ICCM’s TA Score: 4 bullish, 2 bearish.
  • SINT’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, ICCM is a better buy in the short-term than SINT.

Price Growth

ICCM (@Medical/Nursing Services) experienced а +3.85% price change this week, while SINT (@Medical/Nursing Services) price change was -5.49% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -1.62%. For the same industry, the average monthly price growth was -10.72%, and the average quarterly price growth was -10.29%.

Reported Earning Dates

ICCM is expected to report earnings on Nov 18, 2026.

SINT is expected to report earnings on Nov 11, 2026.

Industries' Descriptions

@Medical/Nursing Services (-1.62% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
ICCM
Daily Signal:
Gain/Loss:
SINT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement

ICCM and

Correlation & Price change

A.I.dvisor indicates that over the last year, ICCM has been closely correlated with SINT. These tickers have moved in lockstep 67% of the time. This A.I.-generated data suggests there is a high statistical probability that if ICCM jumps, then SINT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ICCM
1D Price
Change %
ICCM100%
-7.41%
SINT - ICCM
67%
Closely correlated
-4.07%
ILMN - ICCM
31%
Poorly correlated
-4.76%
PEN - ICCM
31%
Poorly correlated
+0.43%
BRKR - ICCM
29%
Poorly correlated
-3.04%
BNGO - ICCM
29%
Poorly correlated
-5.60%
More

SINT and

Correlation & Price change

A.I.dvisor indicates that over the last year, SINT has been closely correlated with ICCM. These tickers have moved in lockstep 66% of the time. This A.I.-generated data suggests there is a high statistical probability that if SINT jumps, then ICCM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SINT
1D Price
Change %
SINT100%
-4.07%
ICCM - SINT
66%
Closely correlated
-7.41%
NVCR - SINT
30%
Poorly correlated
-3.14%
STRRP - SINT
28%
Poorly correlated
+3.16%
SRTS - SINT
26%
Poorly correlated
+0.35%
HYPR - SINT
26%
Poorly correlated
-2.75%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OLED87.453.60
+4.29%
Universal Display Corp
AUST0.800.01
+1.61%
Austin Gold Corp
PLTK2.06N/A
N/A
Playtika Holding Corp
CBRS108.94-9.04
-7.66%
Cerebras Systems Inc
AIAI2.05-0.26
-11.26%
AIAI Holdings Corporation